Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 7/20 | 0.58 |
| ▸ | MAPT | P10636 | 7/20 | 0.58 |
| ▸ | MEN1 | O00255 | 6/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.58 |
| ▸ | HTT | P42858 | 2/20 | 0.58 |
| ▸ | MPL | P40238 | 2/20 | 0.55 |
| ▸ | THRB | P10828 | 4/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.53 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.53 |
| ▸ | NPC1 | O15118 | 5/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.52 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.50 |
| ▸ | RAB9A | P51151 | 3/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29912796 | 1.00 | L3MBTL1 (0.58) | L3MBTL1MAPTMEN1KMT2ATDP1 | |
| SCHEMBL1486044 | 1.00 | L3MBTL1 (0.58) | L3MBTL1MAPTMEN1KMT2ATDP1 | |
| SCHEMBL8689528 | 0.86 | KCNH2 (0.55) | L3MBTL1MAPTMEN1KMT2ATDP1 | |
| SCHEMBL8689532 | 0.86 | KCNH2 (0.55) | L3MBTL1MAPTMEN1KMT2ATDP1 | |
| SCHEMBL1507672 | 0.85 | MAPT (0.62) | L3MBTL1MAPTMEN1KMT2ATDP1 | |
| SCHEMBL3074025 | 0.85 | MAPT (0.62) | L3MBTL1MAPTMEN1KMT2ATDP1 | |
| SCHEMBL31011001 | 0.85 | MAPT (0.62) | L3MBTL1MAPTMEN1KMT2ATDP1 | |
| SCHEMBL30688251 | 0.85 | MAPT (0.62) | L3MBTL1MAPTMEN1KMT2ATDP1 | |
| SCHEMBL29376206 | 0.85 | MAPT (0.62) | L3MBTL1MAPTMEN1KMT2ATDP1 | |
| Trimethylammonium SCHEMBL7090073 | 0.82 | MAPT (0.58) | L3MBTL1MAPTMEN1KMT2ATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11998302-B2 | Thermographic device for measurement of differential temperatures in tissue | WELWAZE MEDICAL INC. (US) | 2024-06-04 | — | — | US | disclosed |
| US-20230200662-A1 | THERMOGRAPHIC DEVICE FOR MEASUREMENT OF DIFFERENTIAL TEMPERATURES IN TISSUE | WELWAZE MEDICAL INC. (US) | 2023-06-29 | — | — | US | disclosed |
| US-11471404-B2 | Composition and method for orally administering one or more active agents to a pet | Société des Produits Nestlé S.A. (CH) | 2022-10-18 | — | — | US | disclosed |
| US-11445917-B2 | Thermographic device for measurement of differential temperatures in tissue | WELWAZE MEDICAL INC. (US) | 2022-09-20 | — | — | US | disclosed |
| US-20220175651-A1 | ORAL CARE COMPOSITION AND DEVICES FORMED THEREWITH | RANIR LLC (US) | 2022-06-09 | — | — | US | disclosed |
| CN-113519839-A | Immune system support compositions and products | 捷通国际有限公司 | 2021-10-22 | — | — | CN | disclosed |
| US-20210244645-A1 | ORAL CARE COMPOSITION AND DEVICES FORMED THEREWITH | JPMORGAN CHASE BANK, N.A. | 2021-08-12 | — | — | US | disclosed |
| US-20210137832-A1 | COMPOSITION AND METHOD FOR ORALLY ADMINISTERING ONE OR MORE ACTIVE AGENTS TO A PET | Société des Produits Nestlé S.A. (CH) | 2021-05-13 | — | — | US | disclosed |
| CN-212606799-U | Immune system support pouch | 捷通国际有限公司 | 2021-02-26 | — | — | CN | disclosed |
| US-10898433-B2 | Composition and method for orally administering one or more active agents to a pet | SOCIETE DES PRODUITS NESTLE SA (CH) | 2021-01-26 | — | — | US | disclosed |
| EP-3758592-A2 | THERMOGRAPHIC DEVICE FOR MEASUREMENT OF DIFFERENTIAL TEMPERATURES IN TISSUE | Welwaze Medical Inc. (US) | 2021-01-06 | — | — | EP | disclosed |
| US-10434061-B2 | Composition and method for orally administering one or more active agents to a pet | SOCIETE DES PRODUITS NESTLE S.A. (CH) | 2019-10-08 | — | — | US | disclosed |
| US-20190209019-A1 | THERMOGRAPHIC DEVICE FOR MEASUREMENT OF DIFFERENTIAL TEMPERATURES IN TISSUE | ZICHY, MARLENE (AR) | 2019-07-11 | — | — | US | disclosed |
| WO-2019113460-A2 | THERMOGRAPHIC DEVICE FOR MEASUREMENT OF DIFFERENTIAL TEMPERATURES IN TISSUE | WELWAZE MEDICAL INC. (US) | 2019-06-13 | — | — | WO | disclosed |
| US-20160158147-A1 | COMPOSITION AND METHOD FOR ORALLY ADMINISTERING ONE OR MORE ACTIVE AGENTS TO A PET | Société des Produits Nestlé S.A. (CH) | 2016-06-09 | — | — | US | disclosed |
| US-7306632-B2 | Leave-in color conditioner | HAIRMARKER LLC (US) | 2007-12-11 | — | — | US | disclosed |
| US-20050198746-A1 | Leave-in color conditioner | HAIRMARKER LLC | 2005-09-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220175651-A1 | ORAL CARE COMPOSITION AND DEVICES FORMED THEREWITH | FHIT, TAS2R40, RBM39 | L3MBTL1 3108/4885MAPT 999/4885MEN1 2984/4885 |
| US-20210244645-A1 | ORAL CARE COMPOSITION AND DEVICES FORMED THEREWITH | FHIT, TAS2R40, RBM39 | L3MBTL1 3108/4885MAPT 999/4885MEN1 2984/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.